Fidelity Investments’s Tevogen Inc TVGN Stock Holding History

Fidelity Investments’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.6K	Sell	9,826 -331	-3%	-$2.64K	﹤0.01%	4263
2026 Q1	$45.9K	Buy	10,157 +8,119	+398%	+$99.5K	﹤0.01%	4166
2025 Q4	$33.7K	Sell	2,038 -82	-4%	-$2.13K	﹤0.01%	4270
2025 Q3	$83.2K	Sell	2,120 -19	-0.9%	-$934	﹤0.01%	3740
2025 Q2	$134K	Sell	2,139 -26	-1%	-$1.48K	﹤0.01%	3478
2025 Q1	$117K	Sell	2,165 -99	-4%	-$6.51K	﹤0.01%	3486
2024 Q4	$117K	Buy	2,264 +2,071	+1,073%	+$135K	﹤0.01%	3481
2024 Q3	$3.56K	Buy	+193	New	+$5.64K	﹤0.01%	4692

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Fidelity Investments's TVGN Position: Q2 2026 in Review

Fidelity Investments reduced its Tevogen Inc (TVGN) stake by 3.3% in Q2 2026, selling an estimated $2.64K and leaving 9,826 shares worth $55.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4263.

Fidelity Investments first reported a position in TVGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $134K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

Fidelity Investments held 9,826 shares of Tevogen Inc worth $55.6K as of Q2 2026.
Fidelity Investments sold 331 Tevogen Inc shares in Q2 2026, an estimated $2.64K.
Tevogen Inc made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4263 holding.
Fidelity Investments first reported a position in Tevogen Inc in Q3 2024 and has held it in 8 quarters since.
Fidelity Investments's Tevogen Inc position peaked at $134K in Q2 2025.
30 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.